BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+7.31%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$164M
AUM Growth
+$164M
(+3%)
Cap. Flow
-$1.1M
Cap. Flow
% of AUM
-0.67%
Top 10 Holdings %
Top 10 Hldgs %
85.32%
Holding
58
New
4
Increased
8
Reduced
3
Closed
4
Top Buys
1 |
Bristol-Myers Squibb
BMY
|
$1.09M |
2 |
DERM
Dermira, Inc.
DERM
|
$956K |
3 |
VRML
Vermillion, Inc.
VRML
|
$890K |
4 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$826K |
5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$766K |
Top Sells
1 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$5.79M |
2 |
InflaRx
IFRX
|
$605K |
3 |
OMED
OncoMed Pharmaceuticals, Inc.
OMED
|
$387K |
4 |
CELG
Celgene Corp
CELG
|
$124K |
5 |
Veracyte
VCYT
|
$114K |
Sector Composition
1 | Healthcare | 96.53% |
2 | Energy | 1.97% |
3 | Consumer Staples | 0.07% |
4 | Consumer Discretionary | 0.05% |
5 | Materials | 0.04% |